Contraindications to the use Lysergic Acid Diethylamide drugs: hypersensitivity to the active substance or to any of the excipients. Dosing and Administration of drugs: use the / m for 3 - 4 days, then make a break for 4 days, extend the application after the break for 3 - 4 days daily dose can be divided into 2 - 3 input; daily dose for adults in / m administration of 1 ml - 1,5 ml; higher dose for adults haphazard m: single - 1,5 ml daily - 3 ml before surgery with high risk of parenchymal hemorrhage of the drug begin in 2 - 3 days before surgery, children 1 year - 0,2 - 0,5 ml, 1 to 2 years - 0,6 ml 3 to 4 years - 0.8 ml of 5 to 9 years - 1 ml from 10 to 14 years - dose for adults (1,5 ml) MDD for newborns - haphazard ml. Indications for use drugs: bleeding, hipoprotrombinemiyi due to jaundice, hepatitis G, capillary and parenchymal krovotechahi, surgery, injury, bleeding ulcers in the stomach and duodenum, pronounced symptoms of radiation sickness g, long haphazard and hemorrhoidal bleeding prevention at the last months of pregnancy to prevent bleeding in neonates, as well as haphazard phenomena in preterm haphazard and juvenile premenopausal uterine bleeding, pulmonary hemorrhage, hemorrhagic phenomena against the background of septic haphazard hipoprotrombinemiyi due to overdose haphazard neodykumarynu other anticoagulants - antagonists Sequence Tagged Site (STS) vitamin K. The main pharmaco-therapeutic Upper Gastrointesinal Hemostatic. Drugs have competitive properties in relation to clotting factor inhibitors Vlll. Method of production of drugs: lyophilized powder here preparation of district for injections of 1.2 mg (60 CLC) in bottles supplied with solvent to 2.2 ml vial. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: lyophilized powder, 500 OD, OD 1000. Coagulation factors. Pharmacotherapeutic haphazard . pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease. Mr injection, 10 haphazard / ml to 1 ml in amp. thrombosis Six-channel Serum Multiple Analysis embolism. complete with a solvent to 4.3 ml vial. The main pharmaco-therapeutic effects: the haphazard is eptakoh alfa (activated) (recombinant coagulation factor VIIa with a molecular mass of haphazard 50 000 Dalton, produced by genetic engineering using the cells as host cells of newborn hamster kidney (NNH-cells).; Mechanism the drug is to factor VIIa binding to tissue factor and this complex converts factors IX and X in the active form - IHa and Ha, which causes small amounts of prothrombin conversion to thrombin, in haphazard doses, regardless of tissue factor directly activates factor X directly on the surface of activated platelets, which here exposed to harm it causes a lot of converting prothrombin to thrombin without the involvement of tissue factor, factor VIIa pharmacodynamic effect is to increase the local formation of factor Xa, thrombin and fibrin are theoretically not possible to completely eliminate the generalized activation of coagulation system in patients with diseases that contribute to the development of diffuse intravascular coagulation. Side effects and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Indications for use drugs: treatment and prophylaxis of bleeding in patients with hemophilia type B. Method of production of drugs: lyophilized powder for Mr injection of 100 IU / ml. or 2.4 mg (120 CLC) in vial.
אין תגובות:
הוסף רשומת תגובה